Sign in

Jeffrey Peppercorn MD

@ethicsdoctorp.bsky.social
734 followers 109 following 21 posts

Oncologist and Bioethicist with interest in health policy and rock n roll. Editor-in-Chief JCO Oncology Practice.

PostsRepliesMedia
Reposted by Jeffrey Peppercorn MD
JCO Journals @jco-asco.bsky.social · 02/06/2026
‼️ #ASCO26 simultaneous publication by McDonald et al: GLP-1 agonists are associated with a significant reduction in breast cancer incidence in women Read the full article: bit.ly/4v88xTu #bcsm
001
Reposted by Jeffrey Peppercorn MD
News Medical @newsmedical.bsky.social · 04/06/2026
GLP-1 drugs, known for weight loss and diabetes, may lower breast cancer risk by nearly 30% in women, says a new study. 👀✨ www.news-medical.net/news/2026060... #BreastCancer #GLP1 @ascocancer.bsky.social
news-medical.net
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence. After propensity-score matching, GLP-1 expo...
002
Reposted by Jeffrey Peppercorn MD
Hannah R. Abrams @hannahrabrams.bsky.social · 20/11/2025
Woah! 41% of stage I/IIA dMMR colon cancers could be overstaged by CT imaging. May need better ways to upfront stage (MRI, ctDNA?) in the neoadjuvant ICI era. #GIOnc #OncSky #MedSky #JCOOP ascopubs.org/doi/10.1200/...
ascopubs.org
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon Cancer | JCO Oncology Practice
PURPOSEThis study assesses the accuracy of radiographic clinical staging by computed tomography (CT) of mismatch repair-deficient (dMMR) colon cancer, given emerging data for neoadjuvant immune…
032
Reposted by Jeffrey Peppercorn MD
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 20/11/2025
"Beyond respectful language, which is the minimum requirement… [this study] reinforces the broader message about maintaining respect for patients as individuals & ensuring that this is reflected in our words & deeds."   @ascocancer.bsky.social @jco-asco.bsky.social @ethicsdoctorp.bsky.social
ascopubs.org
Don't Do Me Like That: Promoting Respectful Language in Oncology Research | JCO Oncology Practice
152
Reposted by Jeffrey Peppercorn MD
Julie Gralow @jrgralow.bsky.social · 13/09/2025
Terrific (&entertaining) piece by @jco-asco.bsky.social OP editor @ethicsdoctorp.bsky.social on what he thinks AI could do to transform oncology practice by 2035. OK Computer! Reflections on How Artificial Intelligence Saved Cancer Care | JCO Oncology Practice ascopubs.org/doi/full/10....
ascopubs.org
OK Computer! Reflections on How Artificial Intelligence Saved Cancer Care | JCO Oncology Practice
052
Reposted by Jeffrey Peppercorn MD
Robert S Miller MD @rsm2800.bsky.social · 14/05/2025
Congrats to ASCO's journal JCO Oncology Practice on your 20-yr anniversary! JCO OP is the unquestioned and authoritative leader on issues of cancer care policy, delivery, & quality ascopubs.org/doi/full/10....
ascopubs.org
Glory Days: Celebrating Two Decades of Advances in Cancer Care on the 20th Anniversary of JCO Oncology Practice | JCO Oncology Practice
121
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 14/06/2025
Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy | JCO Oncology Practice
PURPOSEImmune checkpoint inhibitor (ICI)-induced thyroid dysfunction is a common endocrine immune-related adverse event. Although rates during therapy are well documented, data on post-treatment thyro...
120
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 03/06/2025
Another great #ASCO25 Also wonderful to see my amazing JCO Oncology Practice colleagues! 📝 Loved Dr. DeMichele’s discussion of SERENA-6 and the incredible CHALLENGE trial data for exercise in colon cancer survivors. 🏃‍♂️ And a chance to hang out for a few hours with my daughter! 🥰
020
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 15/05/2025
Glory Days: Celebrating Two Decades of Advances in Cancer Care on the 20th Anniversary of JCO Oncology Practice | JCO Oncology Practice ascopubs.org/doi/10.1200/... A fun collaboration and nostolgic review by those fortunate to serve as Editor-in-Chief over the past 20 years. 🥳
020
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 14/05/2025
Glory Days: Celebrating Two Decades of Advances in #Cancer Care on the 20th Anniversary of JCO Oncology Practice. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #CancerCare #FinancialToxicity #CancerResearch @ethicsdoctorp.bsky.social @fumikochino.bsky.social @jameabraham.bsky.social
052
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 13/05/2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | JCO Oncology Practice
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...
051
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 05/05/2025
Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer | JCO Oncology Practice
PURPOSEClear prognostic communication is associated with improvements in quality of life and suffering for children with advanced illness. Yet recent evidence demonstrates that pediatric oncologists o...
000
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 23/04/2025
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy. ascopubs.org/doi/10.1200/... @ascopost.bsky.social @pallonccop.bsky.social #Immunotherapy #CancerResearch @ethicsdoctorp.bsky.social
032
Reposted by Jeffrey Peppercorn MD
Emilie Gunn @emiliemgunn.bsky.social · 28/04/2025
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here: SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
ascopubs.org
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma | JCO Oncology Advances
101
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 28/04/2025
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan | J...
PURPOSEMedicare Part D beneficiaries who do not qualify for low-income subsidies face high out-of-pocket (OOP) costs for brand-name specialty oral anticancer medications (SOAMs). We calculated how OOP...
000
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 20/04/2025
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice
010
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 17/04/2025
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice
031
Reposted by Jeffrey Peppercorn MD
Jame Abraham, MD, FACP @jameabraham.bsky.social · 15/04/2025
Had a wonderful editorial meeting at @ascocancer.bsky.social headquarters under the leadership of EIC @ethicsdoctorp.bsky.social @acochran12733.bsky.social @fumikochino.bsky.social @ryannipp.bsky.social and others !
152
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 11/04/2025
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly discussed the role of ...
020
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 03/04/2025
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial | JCO Oncology Practice
PURPOSEGuidelines recommend advance care planning (ACP) to improve patient-centered care near the end of life (EOL), but the optimal approach is unknown. This single-blind, patient-level, randomized c...
030
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 20/03/2025
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced #Cancer: A Randomized Clinical Trial. ascopubs.org/doi/10.1200/... @ascopost.bsky.social @pallonccop.bsky.social #PallOnc #SuppOnc #CancerCare @pittpalcare.bsky.social
054
Reposted by Jeffrey Peppercorn MD
Angela Cochran @acochran12733.bsky.social · 19/03/2025
ICYMI: System-Level Transformations to Increase Patient Participation in Clinical Trials ascopubs.org/doi/10.1200/... #JCOOP
ascopubs.org
System-Level Transformations to Increase Patient Participation in Clinical Trials | JCO Oncology Practice
PURPOSEOver the course of the COVID-19 pandemic, the Food and Drug Administration allowed cancer clinical trials to make modifications. As policymakers consider sustaining these modifications, underst...
011
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 13/03/2025
Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice
032
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 22/01/2025
For your listening pleasure: 🎧👂🎙️ Great inaugural Podcast for JCO OP by @fumikochino.bsky.social On the clinical, academic and very personal aspects of financial toxicity play.libsyn.com/embed/episod...
play.libsyn.com
Libsyn Podcast Player
Libsyn Podcast Player
1101
Reposted by Jeffrey Peppercorn MD
Robert S Miller MD @rsm2800.bsky.social · 14/01/2025
The JCO Oncology Practice special issue on financial toxicity in oncology is now online ascopubs.org/toc/op/current. Lots of good articles including a narrative review from Peppercorn (@ethicsdoctorp.bsky.social) et al on validated tools to measure FT ascopubs.org/doi/full/10....
ascopubs.org
JCO Oncology Practice: Vol 21, No 1
054
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 11/01/2025
Financial Toxicity in Older Adults With #Cancer and Their Caregivers. ascopubs.org/doi/abs/10.1... @ascocancer.bsky.social @ascopost.bsky.social #FinancialToxicity #GeriOnc #PallOnc @melissaloh.bsky.social
0103
Reposted by Jeffrey Peppercorn MD
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 11/01/2025
🚨 The #FinancialToxicity special issue of JCO OP is LIVE today! 🚨 We hope these papers will encourage the next gen of researchers to generate, evaluate, & disseminate patient-centered, high-quality, evidence-based medicine & policy solutions to close the affordability gap! ascopubs.org/toc/op/21/1
ascopubs.org
JCO Oncology Practice: Vol 21, No 1
12010
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 11/01/2025
ascopubs.org/journal/op
ascopubs.org
JCO Oncology Practice | ASCO Publications
082
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 11/01/2025
Out today! 🤩 JCO Oncology Practice Special Issue dedicated to the challenge of Financial Toxicity in Oncology. Great work by @fumikochino.bsky.social @ryannipp.bsky.social pulling this issue together.
0146
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 10/01/2025
Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social @ascopost.bsky.social #FinancialToxicity #PallOnc #CostsOfCare #GeriOnc @fumikochino.bsky.social @ethicsdoctorp.bsky.social
032
Reposted by Jeffrey Peppercorn MD
Angela Cochran @acochran12733.bsky.social · 18/12/2024
New review from #JCOOP: Current Trends in Treating Malignant Pleural Effusion: Evidence, Guidelines, and Best Practice Recommendations #openaccess #oncsky #JCOJournals ascopubs.org/doi/10.1200/...
ascopubs.org
Current Trends in Treating Malignant Pleural Effusion: Evidence, Guidelines, and Best Practice Recommendations | JCO Oncology Practice
Malignant pleural effusion (MPE) is common in individuals with cancer and typically reflects advanced disease. Most cases are symptomatic, with dyspnea and pain having a severe effect on the patient's...
062
Reposted by Jeffrey Peppercorn MD
Angela Cochran @acochran12733.bsky.social · 03/01/2025
Alcohol and Cancer: A Statement of the American Society of Clinical Oncology ascopubs.org/doi/10.1200/...
ascopubs.org
Alcohol and Cancer: A Statement of the American Society of Clinical Oncology
Alcohol drinking is an established risk factor for several malignancies, and it is a potentially modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society of Clinical ...
142
Reposted by Jeffrey Peppercorn MD
Jame Abraham, MD, FACP @jameabraham.bsky.social · 18/12/2024
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer ://ascopubs.org/doi/pdf/10.1200/OP-24-00649 @ascocancer.bsky.social @oncoalert.bsky.social @oncbrothers.bsky.social @acochran12733.bsky.social
0116
Reposted by Jeffrey Peppercorn MD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 13/12/2024
Dr. Bianchini describes the 🐘 in the room at #SABCS24. ❓Are PD-L1 and PD1 not created equal in breast? 🔑It is clear, neoadjuvant compared to adj immunotherapy should be given ⚠️ highlights ER low should be included in ICI trials #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social
1135
Reposted by Jeffrey Peppercorn MD
Ilana Schlam @ilanaschlam.bsky.social · 13/12/2024
Wrapping up another fantastic #SABCS! Amazing, practice-changing data were presented. I’ve updated the algorithms and added key studies from the meeting— I finally ran out of space in HR+ disease! #SABCS24 @oncoalert.bsky.social
04619
Reposted by Jeffrey Peppercorn MD
Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 13/12/2024
Remote Symptom Monitoring of Patients With Advanced Lung #Cancer (The ProWide Study): A Randomized Controlled Trial. ascopubs.org/doi/10.1200/... @ascopost.bsky.social #LungCancer #PallOnc #SuppOnc
074
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 04/12/2024
ascopubs.org/doi/10.1200/...
ascopubs.org
Times Like These: A Reflection on Joy in Oncology Practice | JCO Oncology Practice
130
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 30/11/2024
💙💛!
030
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 27/11/2024
BREAKING: 💥 Poll results are in! - in a single institution prospective study of 17 patients - Jelled Cranberry sauce won decisively over homemade cranberry sauce - 53% vs. 47%!* *Further research to optimize serving Jelled Cranberry sauce is needed. 🦃🇺🇸🦃😜
030
Reposted by Jeffrey Peppercorn MD
Dr. Beverly Moy @beverlymoy.bsky.social · 26/11/2024
No matter what's happening in the world, it's so great to know that you have the very best colleagues in the world at Mass General Brigham Breast Center. @ethicsdoctorp.bsky.social and many others. So thankful for them this Thanksgiving.
071
Reposted by Jeffrey Peppercorn MD
John Scalzi @scalzi.com · 25/11/2024
Search your heart. You know it to be true.
1511292109
Reposted by Jeffrey Peppercorn MD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 19/11/2024
#Oncologysky did you already vote once this month? Please make it twice and vote ✍️ 🗳️ in the #ASCO election if you are a member of ASCO!!! I'm lucky enough to be on the ballot 🗳️ this year for an undesignated spot on the Nomination Committee. society.asco.org/about-asco/a... Vote here ⬆️!
0236
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 17/11/2024
New this month in JCO Oncology Practice 🔥 - Special issue on Molecular Testing in Oncology Practice - great papers on the science, use in select diseases, and ethics of testing as the science evolves. #cancer ascopubs.org/doi/10.1200/...
ascopubs.org
Dealing With the Gene Blues | JCO Oncology Practice
0105
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 16/11/2024
Happy to be here on Bluesky! This shot of the Sudbury river in Concord MA seems appropriate as first post to this site. #nature #landscape
181